From Zacks Investment Research: 2025-01-17 03:36:07

Zacks.com highlighted stocks in their Analyst Blog, including Salesforce, Shell, and Gilead Sciences. Salesforce’s strong customer demand and product alignment are boosting its growth, despite competition and economic uncertainties. Shell’s LNG position and buybacks show promise, but concerns about renewable energy and reserve replacement linger. Gilead’s HIV therapy success and pipeline developments are driving growth, although recent setbacks are noted. Overall, these stocks offer potential for investors, but caution is advised due to various factors. Zacks’ top stock-picking strategies have historically outperformed the S&P, offering valuable insights for investors.



Read more at Zacks Investment Research: The Zacks Analyst Blog Salesforce, Shell and Gilead Sciences – January 17, 2025